Acute kidney injury in kidney transplantation

Current Opinion in Nephrology and Hypertension

Volumn 22, Issue 6, 2013, Pages 698-703

  Cooper, James E ^a   Wiseman, Alexander C ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

acute kidney injury; biomarkers; delayed graft function; kidney transplant

Indexed keywords

CREATININE; DIANNEXIN; FATTY ACID BINDING PROTEIN; GLUCOSE; GLUTATHIONE TRANSFERASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYPERTENSIVE FACTOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE 9; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PLACEBO; PRESENILIN 1; PROTEIN; PROTEIN NKTR; RECOMBINANT ERYTHROPOIETIN; SODIUM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ACUTE KIDNEY FAILURE; ARTERIAL GAS; ARTERIAL PH; BLOOD ANALYSIS; CENTRAL VENOUS PRESSURE; CREATININE BLOOD LEVEL; DELAYED GRAFT FUNCTION; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART EJECTION FRACTION; HEMATOMA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTIOUS COMPLICATION; INTERVENTION STUDY; KIDNEY ABSCESS; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LONG TERM CARE; LYMPHOCELE; MEAN ARTERIAL PRESSURE; NON INVASIVE PROCEDURE; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL (TOPIC); POLYOMA VIRUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REPERFUSION INJURY; REVIEW; SODIUM BLOOD LEVEL; URETER STRICTURE; URINALYSIS; URINARY TRACT INFECTION; URINE INCONTINENCE; URINE VOLUME;

ACUTE KIDNEY INJURY; BIOLOGICAL MARKERS; DELAYED GRAFT FUNCTION; DONOR SELECTION; GENE EXPRESSION PROFILING; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; TISSUE AND ORGAN HARVESTING;

EID: 84887019734     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e328365b388     Document Type: Review

References (49)

1. Waikar SS, Liu KD, Chertow GM. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol 2008; 3:844-861.
2. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204-R212.
3. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31.
4. Ricci Z, Cruz D, Ronco C. The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int 2008; 73:538-546.
5. Nakamura M, Seki G, Iwadoh K, et al. Acute kidney injury as defined by the RIFLE criteria is a risk factor for kidney transplant graft failure. Clin Transplant 2012; 26:520-528.
6. Mehrotra A, Rose C, Pannu N, et al. Incidence and consequences of acute kidney injury in kidney transplant recipients. Am J Kidney Dis 2012; 59:558-565.
7. Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 2012; 81:442-448.
8. Liano F, Felipe C, Tenorio MT, et al. Long-term outcome of acute tubular necrosis: a contribution to its natural history. Kidney Int 2007; 71:679-686.
9. Amdur RL, Chawla LS, Amodeo S, et al. Outcomes following diagnosis of acute renal failure in U.S. veterans: focus on acute tubular necrosis. Kidney Int 2009; 76:1089-1097.
10. Mehta RL, Pascual MT, Soroko S, et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int 2004; 66:1613-1621.
11. Chawla LS, Amdur RL, Amodeo S, et al. The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int 2011; 79:1361-1369.
12. Irish WD, Ilsley JN, Schnitzler MA, et al. A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant 2010; 10:2279-2286.
13. Wever KE, Wagener FA, Frielink C, et al. Diannexin protects against renal ischemia reperfusion injury and targets phosphatidylserines in ischemic tissue. PLoS One 2011; 6:e24276.
14. Gaber AO, Mulgaonkar S, Kahan BD, et al. YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multicenter Phase IIa study. Clin Transplant 2011; 25:523-533.
15. Thompson JD, Kornbrust DJ, Foy JW, et al. Toxicological and pharmacokinetic properties of chemically modified siRNAs targeting p53 RNA following intravenous administration. Nucleic Acid Ther 2012; 22:255-264.
16. Molitoris BA, Dagher PC, Sandoval RM, et al. siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury. J Am Soc Nephrol 2009; 20:1754-1764.
17. Lu CY, Winterberg PD, Chen J, Hartono JR. Acute kidney injury: a conspiracy of toll-like receptor 4 on endothelia, leukocytes, and tubules. Pediatr Nephrol 2012; 27:1847-1854.
18. Freitas MC, Uchida Y, Lassman C, et al. Type I interferon pathway mediates renal ischemia/reperfusion injury. Transplantation 2011; 92:131-138.
19. Bergler T, Hoffmann U, Bergler E, et al. Toll-like receptor 4 in experimental kidney transplantation: early mediator of endogenous danger signals. Nephron Exp Nephrol 2012; 121:e59-e70.
20. Ozaki KS, Yoshida J, Ueki S, et al. Carbon monoxide inhibits apoptosis during cold storage and protects kidney grafts donated after cardiac death. Transpl Int 2012; 25:107-117.
21. Caumartin Y, Stephen J, Deng JP, et al. Carbon monoxide-releasing molecules protect against ischemia-reperfusion injury during kidney transplantation. Kidney Int 2011; 79:1080-1089.
22. Pallet N, Rabant M, Legendre C, et al. The nephroprotective properties of recombinant human erythropoietin in kidney transplantation: experimental facts and clinical proofs. Am J Transplant 2012; 12:3184-3190.
23. Hafer C, Becker T, Kielstein JT, et al. High-dose erythropoietin has no effect on short- or long-term graft function following deceased donor kidney transplantation. Kidney Int 2012; 81:314-320.
24. Sureshkumar KK, Hussain SM, Ko TY, et al. Effect of high-dose erythropoietin on graft function after kidney transplantation: a randomized, double-blind clinical trial. Clin J Am Soc Nephrol 2012; 7:1498-1506.
25. Aydin Z, Mallat MJ, Schaapherder AF, et al. Randomized trial of short-course high-dose erythropoietin in donation after cardiac death kidney transplant recipients. Am J Transplant 2012; 12:1793-1800.
26. Siedlecki A, Irish W, Brennan DC. Delayed graft function in the kidney transplant. Am J Transplant 2011; 11:2279-2296.
27. Lodhi SA, Lamb KE, Uddin I, Meier-Kriesche HU. Pulsatile pump decreases risk of delayed graft function in kidneys donated after cardiac death. Am J Transplant 2012; 12:2774-2780.
28. O'Callaghan JM, Knight SR, Morgan RD, Morris PJ. Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis. Am J Transplant 2012; 12:896-906.
29. Moers C, Smits JM, Maathuis MH, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009; 360:7-19.
30. Malinoski DJ, Patel MS, Ahmed O, et al. The impact of meeting donor management goals on the development of delayed graft function in kidney transplant recipients. Am J Transplant 2013; 13:993-1000.
31. Tapiawala SN, Tinckam KJ, Cardella CJ, et al. Delayed graft function and the risk for death with a functioning graft. J Am Soc Nephrol 2010; 21:153-161.
32. Yarlagadda SG, Coca SG, Formica RN Jr, et al. Association between delayed graft function and allograft and patient survival: a systematic review and metaanalysis. Nephrol Dial Transplant 2009; 24:1039-1047.
33. Butala NM, Reese PP, Doshi MD, Parikh CR. Is delayed graft function causally associated with long-term outcomes after kidney transplantation? Instrumental variable analysis. Transplantation 2013; 95:1008-1014.
34. Kayler LK, Srinivas TR, Schold JD. Influence of CIT-induced DGF on kidney transplant outcomes. Am J Transplant 2011; 11:2657-2664.
35. Shapiro R, Halloran PF, Delmonico FL, Bromberg JS. The 'two, one, zero' decision: what to do with suboptimal deceased donor kidneys. Am J Transplant 2010; 10:1959-1960.
36. Massie AB, Desai NM, Montgomery RA, et al. Improving distribution efficiency of hard-to-place deceased donor kidneys: predicting probability of discard or delay. Am J Transplant 2010; 10:1613-1620.
37. Doshi MD, Garg N, Reese PP, Parikh CR. Recipient risk factors associated with delayed graft function: a paired kidney analysis. Transplantation 2011; 91:666-671.
38. Furness PN, Philpott CM, Chorbadjian MT, et al. Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates. Transplantation 2003; 76:969-973.
39. Sorof JM, Vartanian RK, Olson JL, et al. Histopathological concordance of paired renal allograft biopsy cores. Effect on the diagnosis and management of acute rejection. Transplantation 1995; 60:1215-1219.
40. De Serres SA, Varghese JC, Levin A. Biomarkers in native and transplant kidneys: opportunities to improve prediction of outcomes in chronic kidney disease. Curr Opin Nephrol Hypertens 2012; 21:619-627.
41. Chowdhury P, Hernandez-Fuentes MP. Noninvasive biomarkers to guide management following renal transplantation: the need for a multiplatform approach. Curr Opin Organ Transplant 2013; 18:1-5.
42. Bataille A, Abbas S, Semoun O, et al. Plasma neutrophil gelatinase-associated lipocalin in kidney transplantation and early renal function prediction. Transplantation 2011; 92:1024-1030.
43. Hollmen ME, Kyllonen LE, Inkinen KA, et al. Urine neutrophil gelatinaseassociated lipocalin is a marker of graft recovery after kidney transplantation. Kidney Int 2011; 79:89-98.
44. Hoogland ER, de Vries EE, Christiaans MH, et al. The value of machine perfusion biomarker concentration in DCD kidney transplantations. Transplantation 2013; 95:603-610.
45. Heyne N, Kemmner S, Schneider C, et al. Urinary neutrophil gelatinaseassociated lipocalin accurately detects acute allograft rejection among other causes of acute kidney injury in renal allograft recipients. Transplantation 2012; 93:1252-1257.
46. De Serres SA, Mfarrej BG, Grafals M, et al. Derivation and validation of a cytokine-based assay to screen for acute rejection in renal transplant recipients. Clin J Am Soc Nephrol 2012; 7:1018-1025.
47. Li L, Khatri P, Sigdel TK, et al. A peripheral blood diagnostic test for acute rejection in renal transplantation.AmJ Transplant 2012; 12:2710-2718.
48. Haase M, Bellomo R, Devarajan P, et al. Accuracy of neutrophil gelatinaseassociated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 54:1012-1024.
49. Mannon RB, Kirk AD. Beyond histology: novel tools to diagnose allograft dysfunction. Clin J Am Soc Nephrol 2006; 1:358-366.